Medpace Holdings (MEDP) Tops Q2 EPS by 7c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Medpace Holdings, Inc. Reports Second Quarter 2021 Results
July 26, 2021 4:15 PM EDTRevenue of $278.3 million in the second quarter of 2021 increased 35.8% from revenue of $205.0 million for the comparable prior-year period, representing a backlog conversion rate of 17.1%. Net new business awards were $387.6 million in the second quarter of 2021, representing an increase of 52.5% from net new business awards of $254.1 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.39x. Second quarter of 2021 GAAP net income was $39.9 million, or $1.06 per diluted share, versus GAAP net income of $24.1 million, or $0.64 per diluted share, for the comparable prior-year period. Net income margin was 14.3% and 11.8%... More
